Long-term therapy after acute coronary syndromes according to 2023 ESC Guidelines for the management of ACS.

In this interview with Borja Ibáñez, National Centre for Cardiovascular Research CNIC and Fundacion Jimenez Diaz Hospital, Madrid - Spain, one of the Task Force co-ordinators of the ESC 2023 Guidelines for the management of acute coronary sydromes, and Riccardo Asteggiano, Laboratorio Analisi Ricerca Clinica, Turin - Italy, underline the complex aspects of long-term therapy after ACS, mainly concerning antithrombotic management and secondary prevention management.